WebFeb 22, 2024 · securities and exchange commission. washington, d.c. 20549 . form 6-k . report of foreign private issuer pursuant to rule 13a-16 or 15d-16. under the securities exchange act of 1934 WebSep 17, 2024 · Dr. Reddy’s licensed to sell volume-limited amounts of generic lenalidomide in the U.S. beginning on a confidential date after the March 2024 date previously granted to Natco Dr. Reddy’s also licensed to sell generic lenalidomide in the U.S. without volume limitation beginning on January 31, 2026 The earliest licensed entry of any generic …
SEC Filings - drreddys.com
WebJan 20, 2024 · Hyderabad, India; January 20, 2024 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as … WebApr 4, 2024 · Latest SEC filings for Dr. Reddy's Laboratories Limited (RDY). Seeking Alpha - Go to Homepage Entering text into the input field will update the search result … how to make tramadol
DR. REDDY’S LABORATORIES LIMITED - sec.gov
WebMar 28, 2024 · Sequoia Financial Advisors LLC lifted its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Get Rating) by 118.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,531 shares of the co WebDr. Reddy’s Q4 & FY20 Financial Results. Dr. Reddy’s Laboratories announces the launch of FXR™ (obeticholic acid) in India. Dr. Reddy's Laboratories announces the launch of Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market. Dr. Reddy's Laboratories received approval for their NDA, ELYXYB™ (celecoxib oral solution) 25 … WebJun 16, 2024 · HYDERABAD, India-- ( BUSINESS WIRE )--Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that its Annual … muddy cakes